This report outlines a proposed method for the development of cluster group comparators, based on socio-economic similarity and disease prevalence, to enable benchmarking of prescribing. The respiratory therapeutic area is used here to illustrate the method, due to the impact of respiratory illness on the population, the high cost of prescribing respiratory items, recent changes in the evidence base and the potential for prescribing review.
This resource has been retired and is no longer considered an AWMSG-endorsed resource. If you think this resource should be reconsidered for review, please get in touch with AWTTC by emailing awttc@nhs.wales.uk. |
⇩ GP Cluster Level Comparators 736KB (PDF) |
(October 2014)
(Retired - January 2025)